Gene · 338399
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer's disease. | Biomaterials | 2023 | 39491374 | PubTator, text mining | PubMed |
| Open technique of performing total cavopulmonary connection on cardiopulmonary bypass. | Ann Pediatr Cardiol | 2023 | 38817251 | PubTator, text mining | PubMed |
| Strengthening channeling policy: the Finnish approach to protecting domestic online gambling market. | Front Sociol | 2023 | 38274838 | PubTator, text mining | PubMed |
| Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression. | Front Immunol | 2023 | 38259497 | PubTator, text mining | PubMed |
| Does activation of oxytocinergic reward circuits postpone the decline of the aging brain? | Front Psychol | 2023 | 38222845 | PubTator, text mining | PubMed |
| GLP1 Receptor Agonists-Effects beyond Obesity and Diabetes. | Cells | 2023 | 38201269 | PubTator, text mining | PubMed |
| Protein profiling and assessment of amyloid beta levels in plasma in canine refractory epilepsy. | Front Vet Sci | 2023 | 38192726 | PubTator, text mining | PubMed |
The most common founder pathogenic variant c.868G > A (p.Val290Met) in the NPHS2 gene in a representative adult Czech cohort with focal segmental glomerulosclerosis is associated with a milder disease and its underdiagnosis in childhood. | Front Med (Lausanne) | 2023 | 38170106 | PubTator, text mining | PubMed |
| Delayed-Type Hypersensitivity: An Excellent Indicator of Anti-tumor Immunity With Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy. | Cureus | 2023 | 38143707 | PubTator, text mining | PubMed |
| Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases. | Molecules | 2023 | 38138535 | PubTator, text mining | PubMed |
| Improved transition metal photosensitizers to drive advances in photocatalysis. | Chem Sci | 2023 | 38131090 | PubTator, text mining | PubMed |
| Biomarkers associated with the pathogenesis of Alzheimer's disease. | Front Cell Neurosci | 2023 | 38130871 | PubTator, text mining | PubMed |
| 27-hydroxycholesterol causes cognitive deficits by disturbing Th17/Treg balance and the related immune responses in mild cognitive impairment patients and C57BL/6J mice. | J Neuroinflammation | 2023 | 38115100 | PubTator, text mining | PubMed |
| Hong Kong Corpus of Chinese Sentence and Passage Reading. | Sci Data | 2023 | 38097638 | PubTator, text mining | PubMed |
| Case Report: Mutation in TNNI3(c. 544G>A): a novel likely pathogenic mechanism of neonatal dilated cardiomyopathy. | Front Pediatr | 2023 | 38089682 | PubTator, text mining | PubMed |
| Specifications of the ACMG/AMP Variant Classification Guidelines for Germline DICER1 Variant Curation. | Hum Mutat | 2023 | 38084291 | PubTator, text mining | PubMed |
| Cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer's disease. | bioRxiv | 2023 | 38076913 | PubTator, text mining | PubMed |
| Biotransformation of American Ginseng Stems and Leaves by an Endophytic Fungus Umbelopsis sp. and Its Effect on Alzheimer's Disease Control. | Nutrients | 2023 | 38068736 | PubTator, text mining | PubMed |
| Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation. | Nat Commun | 2023 | 38057330 | PubTator, text mining | PubMed |
| A glance through the effects of CD4+ T cells, CD8+ T cells, and cytokines on Alzheimer's disease. | Comput Struct Biotechnol J | 2023 | 38053545 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338399/papers?page=10